136 related articles for article (PubMed ID: 33169578)
1. [Selenoprotein thioredoxin reductase mediated menadione reduction: catalytic properties & inhibition effects].
Zhang N; Sun S; Zhang Y; Yang Y; Zhang Y; Chen J; Xu W; Ma Q; Xu J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):2139-2150. PubMed ID: 33169578
[TBL] [Abstract][Full Text] [Related]
2. Menadione inhibits thioredoxin reductase 1 via arylation at the Sec
Sun S; Xu W; Zhang Y; Yang Y; Ma Q; Xu J
Free Radic Biol Med; 2021 Aug; 172():482-489. PubMed ID: 34186208
[TBL] [Abstract][Full Text] [Related]
3. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
Xu J; Cheng Q; Arnér ES
Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1.
Cheng Q; Sandalova T; Lindqvist Y; Arnér ES
J Biol Chem; 2009 Feb; 284(6):3998-4008. PubMed ID: 19054767
[TBL] [Abstract][Full Text] [Related]
5. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
Sun S; Zhang Y; Xu W; Yang R; Yang Y; Guo J; Ma Q; Ma K; Zhang J; Xu J
Biomed Pharmacother; 2022 Feb; 146():112546. PubMed ID: 34954641
[TBL] [Abstract][Full Text] [Related]
6. The production of reactive oxygen species enhanced with the reduction of menadione by active thioredoxin reductase.
Li J; Zuo X; Cheng P; Ren X; Sun S; Xu J; Holmgren A; Lu J
Metallomics; 2019 Sep; 11(9):1490-1497. PubMed ID: 31359011
[TBL] [Abstract][Full Text] [Related]
7. Inhibition and crosslinking of the selenoprotein thioredoxin reductase-1 by p-benzoquinone.
Shu N; Cheng Q; Arnér ESJ; Davies MJ
Redox Biol; 2020 Jan; 28():101335. PubMed ID: 31590044
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
Engelman R; Ziv T; Arnér ESJ; Benhar M
Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
[TBL] [Abstract][Full Text] [Related]
9. Pyrroloquinoline quinone modulates the kinetic parameters of the mammalian selenoprotein thioredoxin reductase 1 and is an inhibitor of glutathione reductase.
Xu J; Arnér ES
Biochem Pharmacol; 2012 Mar; 83(6):815-20. PubMed ID: 22226931
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
[TBL] [Abstract][Full Text] [Related]
11. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
Anestål K; Arnér ES
J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling.
Zhang Y; Sun S; Xu W; Yang R; Yang Y; Guo J; Ma K; Xu J
Free Radic Biol Med; 2022 Feb; 180():52-62. PubMed ID: 34973363
[TBL] [Abstract][Full Text] [Related]
13. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
[TBL] [Abstract][Full Text] [Related]
14. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
15. High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
Eriksson SE; Prast-Nielsen S; Flaberg E; Szekely L; Arnér ES
Free Radic Biol Med; 2009 Dec; 47(11):1661-71. PubMed ID: 19766715
[TBL] [Abstract][Full Text] [Related]
16. Efficient selenocysteine-dependent reduction of toxoflavin by mammalian thioredoxin reductase.
Gencheva R; Cheng Q; Arnér ESJ
Biochim Biophys Acta Gen Subj; 2018 Nov; 1862(11):2511-2517. PubMed ID: 29807072
[TBL] [Abstract][Full Text] [Related]
17. Acetylation Regulates Thioredoxin Reductase Oligomerization and Activity.
Wright DE; Altaany Z; Bi Y; Alperstein Z; O'Donoghue P
Antioxid Redox Signal; 2018 Aug; 29(4):377-388. PubMed ID: 29117711
[TBL] [Abstract][Full Text] [Related]
18. Selective killing of gastric cancer cells by a small molecule via targeting TrxR1 and ROS-mediated ER stress activation.
Chen W; Zou P; Zhao Z; Weng Q; Chen X; Ying S; Ye Q; Wang Z; Ji J; Liang G
Oncotarget; 2016 Mar; 7(13):16593-609. PubMed ID: 26919094
[TBL] [Abstract][Full Text] [Related]
19. To inhibit TrxR1 is to inactivate STAT3-Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors.
Busker S; Page B; Arnér ESJ
Redox Biol; 2020 Sep; 36():101646. PubMed ID: 32863208
[TBL] [Abstract][Full Text] [Related]
20. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase.
Duan D; Zhang B; Yao J; Liu Y; Sun J; Ge C; Peng S; Fang J
Free Radic Biol Med; 2014 Apr; 69():15-25. PubMed ID: 24407164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
